In the last trading session, 1.53 million shares of the Gritstone Bio Inc (NASDAQ:GRTS) were traded, and its beta was 0.67. Most recently the company’s share price was $0.74, and it changed around $0.0 or -0.95% from the last close, which brings the market valuation of the company to $78.37M. GRTS currently trades at a discount to its 52-week high of $3.33, offering almost -350.0% off that amount. The share price’s 52-week low was $0.67, which indicates that the current value has risen by an impressive 9.46% since then. We note from Gritstone Bio Inc’s average daily trading volume that its 3-month average coming to 2.88 million.
Gritstone Bio Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 4 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 1 recommended GRTS as a Hold, whereas 2 deemed it a Buy, and 0 rated it as Underweight. Gritstone Bio Inc is expected to report earnings per share of $Gritstone bio, Inc. for the current quarter.
Gritstone Bio Inc (NASDAQ:GRTS) trade information
Instantly GRTS has showed a red trend with a performance of -0.95% at the end of last trading. The performance over the last five days has remained in the red territory. The company’s shares are currently down -63.89% year-to-date, but still down -12.42% over the last five days. On the other hand, Gritstone Bio Inc (NASDAQ:GRTS) is -73.02% down in the 30-day period.
The consensus price target as assigned by Wall Street analysts is $4.67, which translates to bulls needing to increase their stock price by 84.15% from its current value. Analyst projections state that GRTS is forecast to be at a low of $3 and a high of $6.
Gritstone Bio Inc (GRTS) estimates and forecasts
Gritstone Bio Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -64.24 percent over the past six months and at a 20.83% annual growth rate that is well above the industry average of 13.30%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 30.25%.
GRTS Dividends
Gritstone Bio Inc’s next quarterly earnings report is expected to be released in May.
